Company intelligence

CRBU

Caribou Biosciences, Inc. · NASDAQ · Healthcare

Price$1.14-4.62% · −$0.06

Market cap112.57MEquity value

P / E-1.1Trailing ratio

Volume5.55MLatest session

Market data

CRBU price chart

TradingView

Related signals

1 min delayed

Browse public CRBU signals with their source context and measured market impact. Open any signal for its permanent analysis page.

CRBUNov 3, 2025-15.07% since signal

Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today>

CRBU stock surged 17.56% after positive trial results. 64% of patients had complete response from CAR-T therapy. Overall response rate in the trial was 82%. FDA recommended a pivotal phase 3 trial for vispa-cel. CB-011 shows promising results for multiple myeloma treatments.

View signal analysis

Research